Glenmark Pharmaceuticals Limited Current Assets

Glenmark Pharmaceuticals Limited (GLENMARK.BO) currently reports a current assets of $110B as of March 2026. That compares with $93B in the prior-year period — up 21.6% year over year. Use the charts on this page to explore Glenmark Pharmaceuticals Limited's current assets history and peer comparisons.

Glenmark Pharmaceuticals Limited's current assets increased from $93B to $110B — a 21.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Glenmark Pharmaceuticals Limited reported $110B in current assets as of March 2026. That compares with $93B in the prior-year period — up 21.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $110B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Glenmark Pharmaceuticals Limited, and consider following GLENMARK.BO for alerts when major investors trade the stock.